ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 953,63
-1,23%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Akari Therapeutics PLC (AKTX)

  7. Akari Therapeutics PLC (AKTX) Actualités

AKTX Akari Therapeutics PLC

1,185
-0,005 (-0,42%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Akari Therapeutics PLC AKTX NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,005 -0,42% 1,185 23:16:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,19 1,17 1,20 1,185 1,19
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/3/202417:53PRNUSKuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to..
11/3/202422:25EDGAR2Form 425 - Prospectuses and communications, business..
11/3/202422:24EDGAR2Form 8-K - Current report
05/3/202422:57EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202414:34EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202414:28EDGAR2Form 8-K - Current report
09/1/202423:25EDGAR2Form D - Notice of Exempt Offering of Securities
04/1/202418:34EDGAR2Form SC 13D/A - General statement of acquisition of..
03/1/202401:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202401:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202400:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202400:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:30EDGAR2Form 8-K - Current report
01/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202322:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
20/10/202322:29EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202322:28EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202322:23EDGAR2Form F-3 - Registration statement by foreign private issuers
12/10/202322:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202314:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/8/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/7/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/7/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/6/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202322:05GLOBEAspira Women’s Health Names Torsten Hombeck as Chief..

Dernières Valeurs Consultées

NASDAQ
AKTX
Akari Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés